INTRODUCTION: To date, studies evaluating mechanical thrombectomy (MT) in distal and medium vessel occlusions (DMVOs) have failed to establish conclusive, high-quality evidence for its clinical benefit. METHODS: Between January 2017 and January 2022, characteristics and outcomes of patients with DMVOs treated with MT or MT + IVtPA were collected at 41 academic centers in North America, Asia, and Europe. Using R software version 4.2.3, propensity score matching using the nearest neighbor matching by controlling for all relevant variables, followed by appropriate descriptive statistics and multivariate logistic regression. RESULTS: After propensity score matching, all differences between groups were resolved, and there was a total of 577 patients included (315 MT alone and 262 MT +IVT). Patients treated with MT + IVT achieved greater rates of TICI 2b-3 (OR = 1.79, 95% CI = 1.02-3.15; P-value= 0.043) than those treated with MT alone, and the rate of modified Rankin score (mRS) 0-2 was greater in the MT + IVT group (n = 171, 65.3%) compared to the MT alone (n = 181, 57.5%) group (OR = 1.52, 95% CI= 1.03-2.24; p-value = 0.034). Sixty-nine patients experienced 90-day mortality, and the rate was comparable between the MT + IVtPA group (n = 30, 11.5%) and the MT alone (n = 39, 12.4%) group (OR = 0.9, 95% CI = 0.53-1.54; p-value = 0.71). Of note, the rate of intracranial hemorrhage (all types) was similar between the MT + IVtPA and MT alone group (OR = 0.85, 95% CI = 0.58-1.26; p-value = 0.43). CONCLUSIONS: MT + IVT showed higher efficacy than MT alone in patients with DMVOs, without higher risks.
No takes yet. Share an insight, caveat, or question.
Ghozy et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: